ArticleJournal for immunotherapy of cancer2022

Immunotherapy combining tumor and endothelium cell lysis with immune enforcement by recombinant MIP-3α Newcastle disease virus in a vessel-targeting liposome enhances antitumor immunity.

Jin-Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.